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Abstract
Background: Current research emphasizes the high prevalence and costs of low back pain (LBP). The STarT Back
Tool was designed to support primary care decision making for treatment by helping to determine the treatment
prognosis of patients with non-specific low back pain. The German version is the STarT-G. The cross-cultural
translation of the tool followed a structured and widely accepted process but to date it was only partially validated
with a small sample.
The aim of the study was to test the psychometric properties construct validity, discriminative ability, internal
consistency and test-retest-reliability of the STarT-G and to compare them with values given for the original English
version.
Methods: A consecutive cohort study with a two-week retest was conducted among patients with non-specific
LBP, aged 18 to 60 years, from primary care practices. Questionnaires were collected before the first consultation, and
two weeks later by post, using the following reference standards: the Roland and Morris disability questionnaire, the
Tampa Scale of Kinesiophobia, the Pain Catastrophizing Scale and the Hospital Anxiety and Depression Scale.
Psychometric properties examined included the tool’s discriminative abilities, whether the psychosocial subscale was
one factor, internal consistency, item redundancy, test-retest reliability and floor and ceiling effects.
Results: There were 228 patients recruited with a mean age of 42.2 (SD 11.0) years, and 53 % were female. The areas
under the curve (AUC) for discriminative ability ranged from 0.70 (STarT-G Subscale - Pain Catastrophizing Scale; CI95
0.63, 0.78) to 0.77 (STarT-G Total - Composite reference standard, CI95 0.60, 0.94). Factor loadings ranged from 0.49 to
0.74. Cronbach’s alpha testing the internal consistency and redundancy for the total/subscale scores were α = 0.52/0.55
respectively. The STarT-G test-retest reliability Kappa values for the total/subscale scores were 0.67/0.68 respectively. No
floor or ceiling effects were present.
Conclusions: The STarT-G shows acceptable psychometric properties although not in exact agreement with the
original English version. The items previously regarded as a psychosocial subscale may be better seen as an index of
different individual psychosocial constructs. The relevance of using the tool at the point of consultation should be
further examined.
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Background
Low back pain (LBP) ranks the highest of all conditions
in terms of years lived with disability, both in Western
Europe and Worldwide [1]. This has enormous eco-
nomic consequences on health care expenditure and loss
of work productivity [2, 3]. Complex biopsychosocial
mechanisms are known to be involved in the develop-
ment of chronic disabling LBP and as a result the vari-
ation in treatment prognosis for individual patients is
considerable [4]. This means, that although a number of
effective treatments are available, selecting appropriate
treatment for individual patients remains a substantial
clinical challenge for primary care where most patients
are managed [5–7].
An internationally agreed research priority is to test
whether the effectiveness of treatment results might be
improved by early identification of patient-subgroups
that are most at risk for developing chronic disabling
pain [8]. Several different approaches for subgrouping
patients with low back pain have been developed [9].
One with feasibility and demonstrated clinical and cost
effectiveness is the STarT Back stratified care approach
involving the use of the Keele STarT Back Tool (SBT),
which has specifically been designed for primary care to
fast-track patients to appropriate treatment based on
prognostic information. The tool assists clinicians in de-
termining an individual’s likely prognosis and consists of
nine items, with the first four relating to biomedical fac-
tors and the last five identifying modifiable psychosocial
risk factors [10]. Patients are then allocated to one of
three prognostic groups (low, medium and high risk)
using established scoring cut-offs which each have differ-
ent matched treatment recommendations [11, 12]. Pa-
tients at low risk receive support to self-manage and are
deliberately not over treated or investigated. Patients at
medium risk are provided with evidence-based physio-
therapy treatment such as exercise and manual therapy,
and patients at high risk receive psychologically in-
formed physiotherapy, which integrates physical and
psychological approaches, aiming at reducing obstacles
to recovery such as unhelpful beliefs and illness behav-
iors. Following promising research findings the approach
is gradually being implemented into routine practice in
the UK [13] and some initial research has reported
promising findings that implementing this approach in
Germany might be possible [14].
The SBT was originally developed in the UK and has
been translated into over 25 languages with 15 articles val-
idating the psychometric properties of different versions
[15]. The German version (STarT-G) was developed fol-
lowing a structured and widely accepted cross-cultural
translation process [16]. In addition, some initial psycho-
metric testing on a small cohort in Switzerland has been
reported [17]. However, as the sample size was small and
only a limited number of measurement properties were
tested, we aimed to conduct a larger scale German valid-
ation study.
The specific objectives of our study were to test the
STarT-G’s construct validity, discriminative ability, in-
ternal consistency and test-retest-reliability and to com-
pare findings with the values given for the original
English version.
Methods
A cohort study with a two-week retest has been con-
ducted. Patients with LBP were recruited from primary
care (general practices and orthopaedic practices both
with free access to care). The first questionnaire (t0)
took place within the practice before consultation, and
the second questionnaire was sent by post (t1) 10 days
later. Patients who did not respond to the postal ques-
tionnaire were contacted by telephone.
Nine general practices and two orthopaedic practices
participated with eight being single-handed, and three
having more than one physician. Before patients were re-
cruited, each practice received training from the study-
team involving:
– An introduction to the STarT Back Tool,
– The informed consent procedure,
– Information about the data collection procedure,
– Information on transferring collected data from the
practice to the study center,
– Information about study reimbursement.
Inclusion criteria were patients with non-specific LBP,
aged 18 to 60 years. The diagnosis of low back pain was
defined as being specific, if a patient had a cauda equina
syndrome, an inflammatory disorder such as ankylosing
spondylitis, or had a suspected serious pathology such as a
tumor or vertebral fracture. No restrictions were placed
on the duration of a patient’s back pain symptoms. Pa-
tients were excluded, if they had consulted the physician
within the last twelve weeks, had undergone spinal surgery
within the last six months, or if they were unable to
complete the study questionnaires due to poor German
language skills. Anonymized information on eligible pa-
tients’ age and gender was obtained regardless of study
participation (“consent list”).
The retest-material was sent to patients 10 days after the
baseline assessment from the study-center. This duration
was set to counter memory effects. Since it was likely that
the health status would change at least for a part of the pa-
tients, an additional question on the subjective estimation
of whether their complaints had changed over this period,
was added [18]. Patients who did not respond to the postal
questionnaire within two weeks were telephoned and
reminded to send the questionnaire, or alternatively asked
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to answer a limited set of questions. The retest-process was
managed by a specifically constructed database to ensure
the maintenance of the predefined time intervals.
Ethical approval was granted by the Ethics Committee
of the University of Heidelberg (registration ID: S-414/
2013). All patients gave their written informed consent
for participation before entering the study in the partici-
pating practice.
Instruments
In addition to the STarT-G, several validated German
versions of reference standard instruments were in-
cluded in the study questionnaire. Disability was opera-
tionalized using the Roland and Morris disability
questionnaire (RMDQ) [19], fear avoidance beliefs were
operationalized with the 17-item-version of the Tampa
Scale of Kinesiophobia (TSK) [20], catastrophizing with
the Pain Catastrophizing Scale (PCS) [21] and depres-
sion with the Hospital Anxiety and Depression Scale
(HADS) [22]. Pain intensity was measured using the mean
of three eleven-point box-scales for least, average (over
the previous two weeks), and current pain [23, 24]. Stan-
dardized questions were used for documentation of the
patients’ age, gender and body-mass-index (BMI), infor-
mation on type of employment, days off work due to LBP
and the duration of the back pain episode [25, 26].
The wording of two questions of the STarT-G were
slightly modified lowering their item-difficulty. Because
of the very high difficulty of item 5 and 8 found within
the first study conducted in Switzerland, a rewording
was undertaken in agreement with the developers of the
SBT [17]. The STarT-G can be obtained from the au-
thors via email.
The definitions for reference standard cases were cata-
strophizing (PCS score ≥ 20), fear (TSK score ≥ 41), depres-
sion (HADS-D score ≥ 8) and disability (RMDQ score ≥ 7)
[11, 22]. Furthermore, a composite reference standard
(CRS; ‘distress’) was determined, defined by individuals that
were a ‘case’ simultaneously in the three psychosocial refer-
ence standard questionnaires: TSK, PCS and HADS de-
pression. Following pretesting with selected LBP patients,
the estimated time for the entire study questionnaire com-
pletion was 15 minutes.
Statistical analyses
Descriptive statistics were calculated to characterize the
study population. The baseline characteristics of study
participants were described to allow interpretability of
the study sample, together with data about drop-outs,
missing data and recruitment rate.
Discriminative ability was assessed by computing re-
ceiver operating characteristic curves with areas under
the curves (AUC) and 95 % confidence interval (CI).
Consistent with the original validation of the English
SBT, this was done for disability, catastrophising and dis-
tress [27]. Adjectives that can be used to describe AUC-
values have been proposed by Hosmer and Lemeshow with
an AUC= 0.5 suggesting ‘no discrimination’, 0.7 to < 0.8
considered ‘acceptable discrimination’, 0.8 to 0.9 considered
‘excellent discrimination’ and >0.9 considered ‘outstanding
discrimination’ [28]. To determine if a patient was a ‘case’
on reference standard instruments, the individual’s scores
were compared to cut-off values given under the subhead-
ing Instruments (see “definitions for reference standard
cases”). Since the CI determined by Hill et al. did not fall
short of AUC= 0.7 [10], equivalence was expected if the
lower CI did not fall short of the same cut-off.
In addition to the AUC, helping to interpret the rela-
tions between the instruments, Spearmans correlation
coefficients were calculated for the STarT-G total and
subscale scores for the RMDQ, TSK, PCS and HADS de-
pression scores in order to be consistent to the approach
of the original SBT authors.
To test if the psychosocial subscale could be regarded
as one factor, a principal components analysis was
undertaken. In general, at least four items should exceed
0.6 [29]. For the original version of the SBT, factor load-
ings between 0.6 and 0.8 were calculated; therefore
equivalence was expected if the STarT-G values would
exceed 0.6 for these five psychosocial items.
To determine internal consistency and item redun-
dancy for the psychosocial subscale, the Cronbach’s
alpha was calculated (poor internal consistency was de-
fined as α < 0.70, item redundancy was defined as α >
0.90) [30]. Since the original SBT validation study re-
ported values ranging between 0.7 and 0.9, equivalence
was expected if Alpha was within this same range.
To investigate the test-retest reliability, Cohen’s quad-
ratic weighted Kappa was calculated for the overall and
subscale scores [31]. Since we had to expect that the
health status would change between t0 and t1 at least for
some patients, and that the STarT-G is responsive, test-
retest calculations were limited to patients who self-
reported their health problems to be unchanged over the
two time-points [32]. A range between Kappa 0.6 and 0.8
was defined as good agreement. The values of 0.79 for the
SBT total score and 0.76 for the subscale score calculated
by Hill et al. lay within this range [10]. Therefore, equiva-
lence was expected with a Kappa score of > 0.6. A sensitiv-
ity analysis was planned excluding retest data gathered via
telephone.
Floor and ceiling effects were defined as present if
more than 15 % of the responders achieved the lowest
or highest possible STarT-G total score [33].
All statistical tests were two-sided and a significance
level of alpha = 5 % was used. Analysis was generally per-
formed using SPSS version 20.0. Principal component
analyses and Kappa calculations were performed using
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the R language and environment for statistical comput-
ing, version 3.1.1 [34].
Sample size
Principal component analysis was expected to be the
procedure with the need for the largest sample size. For
calculation, the formula given by Bortz and Schuster was
considered [29]. With a minimally expected factor load-
ing of 0.4 and a stability of 0.9, a sample size of n = 180
resulted. This led to the conclusion that using the same
sample size of 200 as defined for the original SBT valid-
ation study would be sufficient [10].
Results
Consent for participation was given by 228 patients
(90.1 %), with 25 declining (9.9 %). Consenters and non-
consenters did not differ statistically significant by age or
gender. The mean age of study participants was 42.2 (SD
11.0) years, and 53 % were female (Table 1). During the
previous twelve weeks before t0, 31 patients (13.6 %) re-
ported having taken some sick leave, with a mean of
13.3 (SD 21.2) days off work. The t1 questionnaire was
returned by 181 patients (79.4 %), with an additional 4
patients answering questions on the telephone (1.8 %;
81.1 % in total). Non-respondents at t1 were significantly
younger and more often male. The mean time difference
between the completion of the t0 and the t1 question-
naire was 21.1 (SD 13.3) days.
Due to missing answers (9 questionnaires) or invalid
answers (12 questionnaires, both (missing and invalid
answers) 2 questionnaires), it was not possible to calcu-
late the STarT-G total score for 23 patients and subscale
score for 19 patients.
The AUCs for STarT-G’s ability to discriminate refer-
ence standard cases ranged from 0.70 to 0.77, indicating
acceptable discrimination (Table 2 and Fig. 1a–d). Since
the lower CIs all fell short of 0.7, the STarT-G’s discrim-
inative abilities were not equivalent to the original SBT
version according to our pre-defined criteria.
All correlation coefficients were significant (Table 3),
with values ranging from 0.28 to 0.46.
Factor loadings ranged from 0.49 to 0.74 with items 5
and 6 falling short of the predefined threshold (<0.6) for
equivalence with the original SBT (Table 4).
With α = 0.55 for the subscale score, and α = 0.52 for
the total score, internal consistency was poor. Since
Cronbach’s alpha fell short of the predefined threshold
for equivalence, equivalence to the original version of
the SBT was not reached.
Data from 30 patients, who self-rated their health
problems as unchanged, was included in the analysis
for the test-retest-reliability. With Kappa = 0.67/0.68
(95 % CI 0.46-0.81/0.48-0.84) for the total score and
the subscale score respectively, agreement was good
Table 1 Characteristics of the study population, n = 228
Mean age in years (SD) n 42.2 (11.0) 228
Gender female %, n 53 120
Mean Body-Mass-Index in kg/m2 (SD) n 26.7 (5.0) 225
Employment %, n
Not working 4.9 11
Working≥ 35 hours 62.9 141
Working 15 to 34 hours 25.0 56
Working < 15 hours 2.7 6
Parental or other leave 3.1 7
Trainee/retrainee/prentice 1.3 3
Total 100 224
Mean Pain intensity (SD) n 4.3 (1.7) 225
Mean Disability (RMDQ; SD) n 9.9 (5.2) 204
Duration of current episode %, n
<6 weeks 60.3 135
6 to 12 weeks 8.9 20
>12 weeks to 0.5 year 5.8 13
>0.5 year 25.0 56
Total 100 224
Sick leave within the previous 12 weeks %, na 13.6 31
Mean HADS-D (depression; SD) n 4.7 (3.5) 224
Mean PCS (SD) n 16.7 (10.5) 227
Mean TSK (SD) n 32.9 (6.7) 228
Mean STarT-G total (SD) n 3.9 (2.0) 205
Mean STarT-G subscale (SD) n 2.0 (1.4) 209
STarT-G risk group %, n
Low risk 38.6 80
Medium risk 43.5 90
High risk 17.9 37
Total 100 207
HADS-D Hospital Anxiety and Depression Scale (Depression), PCS Pain
Catastrophizing Scale, RMDQ Roland Morris Disability Questionnaire, TSK
Tampa Scale of Kinesiophobia
aMedically certified sick within twelve weeks before t0
Table 2 Areas under the curve (AUC)
AUC SE 95 % CI
STarT-G Total - RMDQ 0.76 0.04 0.68 0.83
STarT-G Sub - PCS 0.70 0.04 0.63 0.78
STarT-G Sub - HADS-D 0.71 0.05 0.61 0.81
STarT-G Sub - CRS 0.77 0.09 0.60 0.94
HADS-D: Hospital Anxiety and Depression Scale (Depression), PCS: Pain
Catastrophizing Scale, RMDQ: Roland Morris Disability Questionnaire, CRS:
composite reference standard
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and equivalent to the original version of the SBT. An
additional calculation for the risk-groups resulted in
Kappa = 0.28 (95 % CI 0.23-0.55). The planned sensi-
tivity analysis excluding retest data gathered via tele-
phone was not possible as none of the four patients
responding via telephone rated their health problems
as unchanged.
With equivalence to the original SBT version, no floor or
ceiling effects were found for the STarT-G (3.9 % (n = 8) pa-
tients with 0 points; no patients with 9 points).
Discussion
The STarT-G did not show identical psychometric prop-
erties to the original English version although our risk-
group distribution was comparable to the original SBT
validation study. The measurement properties of the
STarT-G showed good test-retest reliability for the total
score and the subscale score, acceptable discriminative
a) RMDQ b) HADS-D
c) PCS d) CRS
Fig. 1 a–d Receiver operating characteristic curves. HADS-D: Hospital Anxiety and Depression Scale (Depression), PCS: Pain Catastrophizing Scale,
RMDQ: Roland Morris Disability Questionnaire, CRS: composite reference standard
Table 3 Spearman correlation coefficients, for each instrument
for STarT-G-total score and subscale score
Total 95 % CI Subscale 95 % CI
RMDQ 0.46a 0.32 0.58 0.39a 0.25 0.52
PCS 0.30a 0.17 0.43 0.40a 0.27 0.52
TSK 0.28a 0.14 0.41 0.30a 0.17 0.42
HADS-D 0.32a 0.19 0.43 0.34a 0.21 0.46
HADS-D Hospital Anxiety and Depression Scale (Depression), PCS Pain
Catastrophizing Scale, RMDQ Roland Morris Disability Questionnaire, TSK
Tampa Scale of Kinesiophobia
asignificant (two-tailed, level = 0.01)
Table 4 Correlation of the variables with the component
STarT-G PC1 h2 u2
Item 5 0.49 0.24 0.76
Item 6 0.51 0.26 0.74
Item 7 0.74 0.55 0.45
Item 8 0.63 0.39 0.61
Item 9 0.65 0.42 0.58
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ability and no floor or ceiling effects. Correlations with the
total score reference standards for disability, and subscale
score for catastrophising were acceptable. The correlations
with the subscale score reference standards for kinesio-
phobia and depression and the test-retest reliability for
risk-group allocation among patients who reported stable
symptoms were weak. The psychosocial subscale of the
STarT-G (items five to nine) should not be regarded as
one distress factor, as the internal consistency of the cor-
responding items was poor.
According to pre-defined criteria the properties of the
STarT-G differ in a number of respects from those of
the original SBT. It is common that measurement tools
perform less well in further validation studies in com-
parison to the developmental study [35]. In addition, we
were not able to identify commonly accepted methods
for the comparison of the measurement properties of
the two instrument versions. A method we found to
compare the tools’ discriminative abilities has been sub-
ject to criticism [27]. Therefore we used a pragmatic ap-
proach, which may have led to an over-estimation of the
differences between both instruments. Nevertheless,
international comparisons between different cohorts
using the STarT-G and the SBT should be undertaken
cautiously.
Our decision to exclude patients who had consulted
their physician within the previous twelve weeks meant
that in comparison to the original study sample and other
SBT related studies we had greater numbers of patients
with a short duration back pain symptoms [36–41]. As a
result, some of the differences in the STarT-G’s psycho-
metric properties may be due to the differences between
the populations studied. The results of Beneciuk et al. sup-
port this perspective, as they specifically analyzed the rele-
vance of the timing of the SBT and found that especially
in acute high-risk patients, tool scores often change within
a few weeks. They therefore suggest further research
examining the potential of repeated measures in helping
to improve the accuracy of prognostic assessment in this
subgroup [42].
In the original SBT validation study the psychosocial
subscale was confirmed to be one overall ‘distress’ fac-
tor. However, this finding was not replicated in our
STarT-G validation study and in fact is consistent with
a Danish validation study which described the SBT as ‘a
multidimensional questionnaire consisting of one or
two screening questions for each of eight underlying con-
structs’ and therefore recommended a stronger item-
based approach for validation [36]. Whilst this finding is
of interest, it might not have a large impact on the STarT-
G’s ability of stratify patients in primary care.
In relation to relevant reference standards our results
identified that the psychosocial subscale of the STarT-G
and the TSK (for fear avoidance beliefs) had the lowest
correlation. The reason for this issue is unclear although
it is noted that in an updated version of the TSK, the in-
strument includes six items less than the version we
used. This reduction was triggered by problems de-
scribed for the TSK factor-structure in the international
literature [20]. Therefore, in future studies it might be
useful to include other instruments for fear avoidance or
other versions of the TSK. For the study described in
this manuscript we slightly modified the wording of two
previous STarT-G items, number five about fear of
movement (kinesiophobia) and number eight about low
mood (depression). It is possible that the lower correl-
ation between the subscale score and reference stan-
dards for kinesiophobia and depression was due to this
re-wording, however this would seem unlikely, especially
since the new formulation of item five resulted in a
higher conformity to the original TSK-item which was
used to develop the STarT-Tool [8].
Missing answers leading to invalid STarT-G scores -
although anticipated - were only a small proportion
(<4 %), with more than half of these due to patients giv-
ing ambiguous responses, e.g. ticks in between the
‘Agree’/’Disagree’ boxes. For the Chinese version of the
SBT missing data was also an issue although to a lesser
extent [41]. Our results suggest that an estimated tenth
of all patients return incomplete STarT-scores making it
impossible to calculate their risk subgroup without fur-
ther enquiry. This occurred despite specific attention
from the study team to ensure appropriate instructions
were in bold, such as ‘answer each question if possible
and try not to spend too long over your answers but
pick the answer that first comes to mind’. In clinical
practice therapists clearly have the opportunity to ask
patients if this occurs. However, we recommend that a
clear definition and evaluation method of missing-data
for the SBT is considered in order that more responses
with missing data are able to be used.
In Germany, it is likely that physiotherapists and
primary care physicians will be the primary users of
the STarT-G [13]. This study, provides them with
clear information on the instrument’s measurement
properties. The stratification tool is designed to assist
clinicians in their decision-making process and not to
replace their decision-making. In addition, the STarT
Back approach upskills physiotherapists, through a
training course, to address the complex needs of
high-risk patients through the delivery of ‘psycho-
logically informed physiotherapy’. Evidence suggests
that trained physiotherapists are effective in managing
around 85 % of this high-risk complex patient sub-
group [43–46]. Nevertheless, the systematic review by
Kenny et al. concludes that, from an international
perspective, the SBT should still be considered as be-
ing in a developmental stage and should therefore be
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used with caution in practice [15]. Our results indi-
cate that this also applies for the German version.
Strengths of this study were that the design was clearly
planned a priori and rigorously applied. Experiences
from a first small validation pilot in Switzerland rein-
forced the selection of primary care practices as the ap-
propriate setting for this study since the clinical context
has a strong influence on the answers patients provide.
Moreover, in contrast to the Swiss study, pre first-
contact consultation as the first time-point for adminis-
trating the STarT-G was chosen to include patients who
had not yet received any treatment [17, 47]. In addition,
a half-year mailing is currently being carried out, to de-
termine the predictive ability of the STarT-G. Other
strengths include achieving an appropriate sample size
and ensuring non-responders were contacted by tele-
phone to ensure a high follow-up rate. In respect to
interpreting the test-retest-reliability findings some cau-
tion is appropriate, since the Kappa-value calculations
were limited to a relatively small subsample of patients
who self-reported their health problems as being un-
changed for the observed study period.
The potential for cost savings and better cost-
effectiveness of the STarT-approach has been demonstrated
by Hill et al. in a large randomized controlled trial [11] and
is also supported by the results from a prospective
population-based sequential comparison observing the im-
plementation of the STarT-Back-Approach in routine
health care [13]. Nevertheless, results have yet to be repli-
cated in other countries. Foster et al. propose that random-
ized trials are the preferred optimal design for this [9].
Correspondingly, the next step should be a feasibility pilot
to examine the approach in Germany and provide informa-
tion to help develop a clear implementation strategy. We
have therefore conducted a related qualitative study with
GPs and physiotherapists to compliment this research [14].
Conclusion
The STarT-G shows overall acceptable psychometric
properties, although some differences with the original
English version were identified. These included the items
previously regarded as a psychosocial subscale being
found to be more than one construct, and so we recom-
mend this subscale is better understood to be a collec-
tion of individual psychosocial items. Further research
utilizing the STarT-G should consider our findings and
pay attention to establishing methods to deal with miss-
ing values.
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